wegovy mash - Search News

Order byBest matchMost fresh

News

MASH, Wegovy and Novo Nordisk

Fierce Pharma · 1h

Novo's Wegovy picks up 3rd indication with key FDA approval in the liver disease MASH

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug approved in a severe form of fatty liver disease. | The FDA has signed off on an accelerated approval for Novo Nordisk's Wegovy to treat certain adults with metabolic-associated steatohepatitis.

Continue reading

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

PharmExec · 9m

Novo Nordisk’s Soar Grows Following Accelerated Approval of Wegovy for MASH and Liver Fibrosis

Wegovy Approved for MASH With Fibrosis, No Cirrhosis

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

1h

Novo Nordisk stock soar 5% today: here’s why analysts are bullish

Novo Nordisk stock gains as FDA expands Wegovy use, while Ozempic price cut aims to boost access and defend market share.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results